Browse > Article
http://dx.doi.org/10.3350/kjhep.2010.16.2.168

Could patients who underwent hepatic resection due to hepatocellular carcinoma with high alpha-fetoprotein be monitored for recurrence by alpha-fetoprotein level?  

Shin, Woo-Young (Department of Surgery, Chonnam National University Medical School)
Suh, Kyung-Suk (Department of Surgery, Seoul National University College of Medicine)
Kim, Tae-Hoon (Department of Surgery, Seoul National University College of Medicine)
Jeon, Young-Min (Department of Surgery, Seoul National University College of Medicine)
Yi, Nam-Joon (Department of Surgery, Seoul National University College of Medicine)
Lee, Kuhn-Uk (Department of Surgery, Seoul National University College of Medicine)
Publication Information
Clinical and Molecular Hepatology / v.16, no.2, 2010 , pp. 168-175 More about this Journal
Abstract
Background/Aims: The follow-up strategy after hepatectomy for hepatocellular carcinoma (HCC) usually depends on the experience of physician, resulting in frequent imaging studies, which leads to increased cost. Hence, we investigated the role of monitoring alpha-fetoprotein (AFP) levels after hepatectomy in patients with preoperative high AFP. Methods: From January 2000 to December 2004, 66 patients who underwent curative hepatectomy due to HCC with preoperative AFP level >400 ng/mL were reviewed. Changes in AFP level after the operation were investigated. The recurrence was suspected in case of two consecutive increase of AFP over cut-off value. Cut-off value was determined by ROC curve. All patients were divided into 2 groups: patients who met the definition (Group S) and those who didn't (Group D). Results: AFP level of 20 ng/ml was proposed as the cut-off value for diagnosis of recurrence by ROC curve. Thirty two patients who didn't have the AFP level decreased below 20 ng/ml after the resection had HCC recurred, whereas 16 out of 34 patients who had AFP decreased had tumor recurrence. The AFP level of patients without recurrence was kept below 20 ng/ml during the follow-up. The AFP level of 44 out of 48 recurred patients increased over 20 ng/ml upon recurrence. By definition, group D were 5 patients. In 4 patients of group D, the AFP level didn't increase above 20 ng/ml upon recurrence. These patients had HCC and they recurred 1 year after the surgery. Conclusions: In patients with preoperative AFP level >400 ng/ml, the AFP level tended to increase above 20 ng/ml at recurrence mostly within 1 year. Hence, we proposed that these patients could be monitored by only AFP until 1 year after surgery.
Keywords
Hepatocelluar carcinoma; Surveillance; Alpha-fetoprotein; Recurrence;
Citations & Related Records

Times Cited By SCOPUS : 1
연도 인용수 순위
1 Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000;232:10-24.   DOI   ScienceOn
2 Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236.   DOI   ScienceOn
3 Bloomer JR, Waldmann TA, McIntire KR, Klatskin G. Alpha-fetoprotein in noneoplastic hepatic disorders. Jama 1975;233:38-41.   DOI   ScienceOn
4 Johnson PJ. The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Dis 2001;5:145-159.   DOI   ScienceOn
5 Tateishi R, Shiina S, Yoshida H, Teratani T, Obi S, Yamashiki N, et al. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Hepatology 2006;44:1518-1527.   DOI   ScienceOn
6 Kanematsu T, Furuta T, Takenaka K, Matsumata T, Yoshida Y, Nishizaki T, et al. A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 1989;10:98-102.   DOI
7 Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998;28:296-301.   DOI   ScienceOn
8 Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. Am J Gastroenterol 2002;97:2886-2895.   DOI   ScienceOn
9 Poon R, Fan S, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Annals of surgery 2000;232:10-24.   DOI   ScienceOn
10 Yanaga K, Takenaka K, Yamamoto K, Nishizaki T, Shirabe K, Shimada M, et al. Cardiac complications after hepatic resection. Br J Surg 1996;83:1448-1451.   DOI   ScienceOn
11 Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004;130:417-422.
12 Miyamoto H, Imamura K, Kojima A, Takenaka H, Hara N, Ikenouchi A, et al. Survey of nasal colonization by, and assessment of a novel multiplex PCR method for detection of biofilm-forming methicillin-resistant staphylococci in healthy medical students. J Hosp Infect 2003;53:215-223.   DOI   ScienceOn